FDA Product Code DXT: Injector And Syringe, Angiographic
Leading manufacturers include Bayer Medical Care, Inc., Acist Medical Systems, Inc. and C.R. Bard, Inc..
FDA 510(k) Cleared Injector And Syringe, Angiographic Devices (Product Code DXT)
About Product Code DXT - Regulatory Context
510(k) Submission Activity
210 total 510(k) submissions under product code DXT since 1978, with 210 receiving FDA clearance (average review time: 146 days).
Submission volume has increased in recent years - 10 submissions in the last 24 months compared to 2 in the prior period - suggesting growing market activity in this device classification.
FDA 510(k) Review Time - DXT Product Code
Recent submissions under DXT have taken an average of 198 days to reach a decision - up from 144 days historically. Manufacturers should account for longer review timelines in current project planning.
DXT devices are reviewed by the General Hospital panel. Browse all General Hospital devices →